Do You Know How Cold-Chain Requirements for the COVID-19 Vaccine Can Impact its Time to Launch?

COVID-19 Vaccine cold supply chain
The Good News: The Vaccines Work


News of promising results in COVID-19 vaccine research has brought a glimmer of hope to people around the world. Within the space of two weeks, both Pfizer and Moderna have announced that early results of their front-runner vaccines show an effectiveness rate of about 95%. The news catalyzed an upsurge in the stock market and spurred governments around the world to begin planning for delivering the vaccines to the most vulnerable populations.


The Bad News: Delivering the Vaccine Will Be Challenging


While the world’s attention has been on the vaccine as a way out of the COVID-19 crisis, distributing the vaccine globally will require one of the largest logistical operations in modern history. The most significant barrier to large-scale distribution is the requirement of a seamless cold-chain. Pfizer’s vaccine needs to be stored at an ultra-cold -75C, while Moderna’s vaccine requires storage at … Read more...